SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-318982
Filing Date
2018-11-06
Accepted
2018-11-06 07:20:59
Documents
4
Period of Report
2018-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d651294d8k.htm 8-K 17954
2 EX-3.1 d651294dex31.htm EX-3.1 9593
3 EX-99.1 d651294dex991.htm EX-99.1 61025
4 GRAPHIC g651294g1106045208771.jpg GRAPHIC 4207
  Complete submission text file 0001193125-18-318982.txt   95954
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 181161487
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10